Biomerica Inc (BMRA)
0.4401
0.00 (0.00%)
USD |
NASDAQ |
Jul 01, 16:00
0.4462
+0.01
(+1.39%)
After-Hours: 20:00
Biomerica Enterprise Value: 2.084M for July 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| July 01, 2024 | 2.084M |
| June 28, 2024 | 2.079M |
| June 27, 2024 | 2.242M |
| June 26, 2024 | 2.318M |
| June 25, 2024 | 1.828M |
| June 24, 2024 | 1.722M |
| June 21, 2024 | 2.222M |
| June 20, 2024 | 2.252M |
| June 18, 2024 | 3.623M |
| June 17, 2024 | 4.606M |
| June 14, 2024 | 4.387M |
| June 13, 2024 | 4.101M |
| June 12, 2024 | 4.438M |
| June 11, 2024 | 4.438M |
| June 10, 2024 | 4.269M |
| June 07, 2024 | 3.778M |
| June 06, 2024 | 4.436M |
| June 05, 2024 | 4.037M |
| June 04, 2024 | 4.382M |
| June 03, 2024 | 4.538M |
| May 31, 2024 | 4.448M |
| May 30, 2024 | 5.279M |
| May 29, 2024 | 5.279M |
| May 28, 2024 | 4.976M |
| May 24, 2024 | 5.211M |
| Date | Value |
|---|---|
| May 23, 2024 | 5.497M |
| May 22, 2024 | 5.329M |
| May 21, 2024 | 5.750M |
| May 20, 2024 | 5.792M |
| May 17, 2024 | 5.872M |
| May 16, 2024 | 4.892M |
| May 15, 2024 | 4.925M |
| May 14, 2024 | 4.774M |
| May 13, 2024 | 4.824M |
| May 10, 2024 | 4.574M |
| May 09, 2024 | 5.006M |
| May 08, 2024 | 4.606M |
| May 07, 2024 | 4.286M |
| May 06, 2024 | 4.576M |
| May 03, 2024 | 4.101M |
| May 02, 2024 | 4.774M |
| May 01, 2024 | 5.280M |
| April 30, 2024 | 4.707M |
| April 29, 2024 | 3.638M |
| April 26, 2024 | 5.871M |
| April 25, 2024 | 6.042M |
| April 24, 2024 | 6.675M |
| April 23, 2024 | 6.826M |
| April 22, 2024 | 6.872M |
| April 19, 2024 | 6.966M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.722M
Minimum
Jun 24 2024
162.62M
Maximum
Mar 19 2020
39.74M
Average
36.96M
Median
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 576.11M |
| Retractable Technologies Inc | -10.52M |
| Xtant Medical Holdings Inc | 106.02M |
| Asensus Surgical Inc | 83.24M |
| Catheter Precision Inc | 1.461M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.918M |
| Revenue (Quarterly) | 1.017M |
| Total Expenses (Quarterly) | 3.017M |
| EPS Diluted (Quarterly) | -0.11 |
| Gross Profit Margin (Quarterly) | -14.65% |
| Profit Margin (Quarterly) | -188.6% |
| Earnings Yield | -84.07% |
| Normalized Earnings Yield | -84.07 |